The Foundation will invest up to $30 million over next three years to programs that support the mental health and well-being of communities with an emphasis on substance use disorders INDIANAPOLIS–(BUSINESS WIRE)–The Anthem Foundation, which will become Elevance Health Foundation on June 28, 2022, today announces the commitment of $13 million in grants to promote … [Read more…]
CARLSBAD, Calif.–(BUSINESS WIRE)–Alphatec Holdings Inc. (Nasdaq: ATEC) announced that it will host an Investor Day at the Company’s headquarters in Carlsbad, CA, today. The event, which will highlight ATEC’s commitment to revolutionizing the approach to spine surgery and the Company’s long-term financial outlook, will begin at 8:15 a.m. PT and conclude at approximately 12:00 p.m. … [Read more…]
The Seeding The Future Global Food System Challenge provides monetary awards in the form of grants and prizes totaling up to one million US dollars annually CHICAGO–(BUSINESS WIRE)–The Institute of Food Technologists (IFT), in collaboration with the Seeding The Future Foundation, is proud to announce the return of the Seeding The Future Global Food System … [Read more…]
Partnership to focus on manufacturing clinical materials for future clinical studies PHILADELPHIA–(BUSINESS WIRE)–iECURE, a gene editing company focused on mutation-agnostic in vivo gene insertion, or knock-in, editing for the treatment of liver disorders with significant unmet need, and Center for Breakthrough Medicines (CBM) today announced the companies have entered into a strategic collaboration wherein CBM … [Read more…]
With fundamental advancements made by the founding team, Terremoto’s lysine-based covalency platform holds the potential to expand the covalent drug alphabet and create both best-in-class and first-in-class small molecule medicines Financing co-led by renowned life-science investors OrbiMed and Third Rock Ventures SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Terremoto Biosciences, a biotechnology company leveraging the power of lysine-based … [Read more…]
Open-Label Trial in Patients with Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations SAN DIEGO–(BUSINESS WIRE)–Endeavor BioMedicines, a clinical-stage biotechnology company targeting the core drivers of terminal diseases including oncology and fibrosis, today announced the first patient has been dosed in an open-label Phase 2 study evaluating ENV-101 (taladegib) in patients with advanced solid … [Read more…]
Company Reaches Milestone During Stroke Awareness Month, Serving as a Reminder to Learn the Signs of Stroke CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that 10,000 patients have been treated in the U.S. with its technologies for stroke since 2020. The company’s current portfolio includes the Zoom Stroke Solution™ and TracStar® LDP technologies for ischemic … [Read more…]
MENLO PARK, Calif.–(BUSINESS WIRE)–Frazier Life Sciences announced the addition of Tao Fu as a Venture Partner. He has over 25 years of business development, general management, operations, strategy, and commercial leadership experience in the pharmaceutical and biotech industry. Mr. Fu most recently served as President & Chief Operating Officer and then Chief Strategy Officer for … [Read more…]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced that members of its executive team will participate in the following upcoming investor conferences: Cowen’s Virtual 3rd Annual Oncology Innovation Summit on Thursday, June 2, 2022. Fireside chat … [Read more…]
IRVINE, Calif.–(BUSINESS WIRE)–Genomic Testing Cooperative (GTC) today announced it received CE-IVD marks for its Hematology Profile Plus, Solid Tumor Plus as well as its liquid biopsy profiles for both solid tumors and hematology that are designed to provide a wide range of clinically actionable insights about a patient’s tumor. The CE mark will allow GTC … [Read more…]
